Position in MIRA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,677
-$5,230 QoQ
Shares Held
1,772
-72.6% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 26 holders
Holding Since
Sep 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MIRA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026UBS Group AG holds $17,056,271,930 across 20 Drug Manufacturers - General names. MIRA ranks #19 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,865,931 | $4,636,914,000 | |
| 2 | ABBV |
AbbVie Inc.
|
12,845,120 | $3,232,345,993 | |
| 3 | JNJ |
Johnson & Johnson
|
11,036,891 | $2,803,039,201 | |
| 4 | MRK |
Merck & Co., Inc.
|
13,744,783 | $1,766,204,613 | |
| 5 | AMGN |
Amgen Inc
|
3,308,695 | $1,198,144,628 | |
| 6 | AZN |
Astrazeneca PLC
|
5,297,462 | $1,004,504,738 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,503,294 | $568,946,162 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,876,439 | $511,460,413 |
All Filings in MIRA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,677 | 1,772 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $6,907 | 6,456 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $4,077 | 2,700 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $293 | 216 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $605 | 500 | Shares | Defined | 2025-08-14 | |
| 2024-06-30 | $18,820 | 29,546 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,248 | 4,771 | Shares | Sole | 2024-05-13 | |
| 2023-09-30 | $116 | 25 | Shares | Sole | 2023-11-09 | |
| No filing history on record for this holder in this stock. | ||||||